How the CDC Made 30,000 Polio Diagnoses Disappear
The polio vaccine was licensed in the U.S. in 1954. From ‘50 thru ‘55, the striped and clear portions of the bars represent about 85% of the reported cases, or 30,000 per year, on average. Those cases were automatically eliminated by two radical changes the CDC made to the diagnostic parameters and labeling protocol of the disease as soon as the vaccine was licensed—30,000 cases a year we were subsequently told were eliminated by the vaccine.
NVIC Will Stand With Parents at October 23-25 Vaccine Truth and Freedom Rally in Atlanta
In the spring of 1986, NVIC co-founder Kathi Williams and I gathered with a small group of parents in Atlanta, Georgia to hold the first public demonstration demanding that the Centers for Disease Control (CDC) be truthful with the American public about vaccine injuries and deaths. We held up signs with photos of children who had died or been brain injured by toxic whole cell DPT vaccine to witness and honor them, the children who had no voice…
Mercury and the Synergistic Toxicity of Vaccines
In an interview with Paul A. Offit, MD, chief of the division of infectious diseases at Children’s Hospital of Philadelphia, the interviewer asked Dr. Offit about the toxicity of mercury contained in some vaccines in the form of the organic compound known as Thimerosal. The context of the question had to do with the specific type of mercury called ethylmercury and whether…
NVIC Questions FDA Fast Tracking of Squalene Adjuvanted Flu Vaccine
The non-profit National Vaccine Information Center (NVIC) is questioning the basis for the fast tracked licensure by the U.S. Food and Drug Administration (FDA) of a squalene-adjuvanted influenza vaccine for use in seniors over age 65. The Novartis MF59 adjuvanted Fluad vaccine was approved for accelerated licensure by the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Sept. 15, 2015 primarily using limited…
Public Comment: Opposition to Fast Track Licensure of MF59 Adjuvanted Fluad
Squalene adjuvants hyper-stimulate the immune system and have been linked with development of autoimmunity, narcolepsy and other chronic disease. Based on the very limited safety and immunogenicity evidence submitted by Novartis, MF59 adjuvanted Fluad vaccine should not be fast tracked to licensure for use by seniors over age 65 in the U.S. for the following…
My Immunocompromised Daughter Is “The Kid Who Can’t Be Vaccinated”
My sweet E was born healthy 16 years ago following an uncomplicated pregnancy. She had great Apgars and was amazing at breastfeeding right from the start. At E’s two-week check-up, I questioned the pediatrician on the necessity of the hepatitis B vaccine, which I had declined in the hospital due to “extreme” intuition. I didn’t understand why she needed the vaccine: I did not have hepatitis B, and she was not in a high-risk group as she was not…